ICU Medical (NASDAQ:ICUI) (NASDAQ: ICUI), headquartered in San Clemente, California, is a global manufacturer of infusion therapy and critical care medical devices. The company designs, develops and provides a broad range of products focused on vascular access, infusion management and safety for acute and ambulatory care settings. Its solutions include needle-free connectors, IV sets, catheters and infusion pumps, which aim to improve clinical efficiency, patient comfort and healthcare worker protection.
Established in 1984 by George S. Demetri, ICU Medical initially gained prominence through pioneering needle-free IV systems that reduced needlestick injuries and contamination risks. Over the years, the company has expanded its portfolio and geographical reach, notably completing the acquisition of Hospira’s global infusion systems business in 2017. This strategic move strengthened ICU Medical’s position in Europe, Latin America, Asia-Pacific and North America, adding established drug-delivery platforms and manufacturing facilities to its operations.
ICU Medical operates two primary business segments: Infusion Therapy and Critical Care. The Infusion Therapy segment offers devices such as IV catheters, protective device systems and electronic infusion pumps, while the Critical Care segment provides products for oncology drug compound safety, hemodynamic monitoring and closed system transfer devices (CSTDs). This diversified offering enables ICU Medical to address a variety of clinical challenges, from infection control to precision drug delivery, across hospitals, clinics and ambulatory care centers.
Supported by an experienced executive leadership team and a board of directors, ICU Medical continues to invest in research and development to introduce innovative solutions that enhance patient safety and clinical outcomes. The company’s global manufacturing footprint and direct sales channels enable it to serve healthcare providers in over 100 countries, reinforcing its commitment to high-quality standards, regulatory compliance and continuous customer engagement.
